Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes
about
Hepatitis C genotype 4: The past, present, and futureBurden of pediatric hepatitis CVertical hepatitis C virus transmission: Main questions and answersEfficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysisSymptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver diseaseThe Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.Neuropsychological functioning and health-related quality of life: pediatric acute liver failure study group results.Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in childrenNeuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature reviewManaging pediatric hepatitis C: current and emerging treatment options.Chronic hepatitis C virus infection in children and adolescents: Epidemiology, natural history, and assessment of the safety and efficacy of combination therapy.Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.Hepatitis B and C.Failure to Test and Identify Perinatally Infected Children Born to Hepatitis C Virus-Infected Women.Health-related Quality of Life in Pediatric Patients With Chronic Hepatitis B Living in the United States and Canada.Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children.Cognitive function and endogenous cytokine levels in children with chronic hepatitis C.Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes.Current treatment options and response rates in children with chronic hepatitis C.Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C.Quality of Life in Adolescents with Hepatitis C Treated with Sofosbuvir and Ribavirin.Families Living with Blood-Borne Viruses: The Case for Extending the Concept of "Serodiscordance".Treatment of hepatitis C in children.Hepatitis C virus infection in children and adolescents.Hepatitis C virus infection in children in the era of direct-acting antiviral.Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C
P2860
Q26775815-DA667BC3-E8A6-45DB-9B27-FF36510E925BQ27025476-ADB690A0-A9C8-4822-B1D6-ABD87E9F5CC0Q28248241-AD73EE21-E723-43D3-9E7F-341C22DD68C9Q28281519-AD094620-9D6E-462D-A217-03144741B11AQ33596269-BDCC787C-6752-4731-A97F-3534656C4E1FQ33621649-74318B7E-B9F4-4A7F-8FD9-81B1B47D370BQ34588247-F8133065-184D-4D17-A339-1485DA04F11DQ34771736-7ACAF5EA-76FA-44FD-874B-9E68963D0C3DQ34861058-BD9D98E6-77E4-4E49-A7A8-CD59B57E3657Q36638638-DDAE3CD1-1F41-4D3E-8569-CEB939BAEC9BQ37316248-323C35F7-32D2-4F04-B002-3F67989CED36Q37561618-92F45478-1AB6-495B-A1D7-8ABAEB64FBA2Q38635796-4DD5CD4B-E4F6-42DC-9440-8531A28710ADQ39305112-C42563E2-D974-4C12-BC8A-89CAD67E55BEQ40076192-C2BD4EB8-6A94-4889-8E77-0A24C61839ECQ40341796-098137B9-BCC5-482D-8FFE-329D7EDBCEB4Q41535163-7AE3A4F1-972C-497E-9518-1D1099CAE1D3Q41605494-B97787E6-B29E-491E-94F3-AD46E2D75795Q42222368-96101B92-FB52-4DFD-B791-EAD19FF2DA4FQ43046510-13ADF0E2-8406-4470-A09C-36115EE20BC6Q44320413-ECD4FAD4-F652-46BE-87FE-280113F0A6CFQ45074467-340595DC-95C7-4166-A2F5-78F470760C8EQ47103354-2C6666BB-AF6B-4130-A978-D78C5031ECFDQ50560594-973B0475-00E0-42A6-B111-FBBB4A6C47C8Q54277218-1101561C-5BB7-4930-A3D7-C99BB179DC01Q55381219-6D18C59D-0B68-4D60-8DB1-AADD2D9D796AQ56395991-62BEA31D-2B69-4BCB-B032-0A96ECB8537C
P2860
Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@ast
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@en
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@nl
type
label
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@ast
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@en
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@nl
prefLabel
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@ast
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@en
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@nl
P2093
P2860
P1476
Impact of Hepatitis C Virus In ...... nitive, and Emotional Outcomes
@en
P2093
Barbara Haber
James R Rodrigue
Karen F Murray
Kathleen B Schwarz
Lesley J Smith
Maureen M Jonas
Michael R Narkewicz
Parvathi Mohan
Patricia Robuck
Philip Rosenthal
P2860
P356
10.1097/MPG.0B013E318185998F
P407
P577
2009-03-01T00:00:00Z